CCR5 and HIV-1 infection: This modification effectively inhibited HIV-1 infection and showed stable CCR5 disruption in secondary repopulating hematopoietic stem cells, offering a promising foundation for future HIV-1 therapies involving CCR5-edited HSC transplantation [80].